Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1- [11C]-acetate PET during radiotherapy: preliminary results.
暂无分享,去创建一个
Jens Sörensen | Alexandru Daşu | J. Sörensen | I. Turesson | S. Johansson | Aijun Sun | Silvia Johansson | Ingela Turesson | A. Dasu | Aijun Sun
[1] S. Bergmann,et al. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] C. Visser,et al. Carbon-11 acetate as a tracer of myocardial oxygen consumption , 2001, European Journal of Nuclear Medicine.
[3] D. Chinkes,et al. Regional acetate kinetics and oxidation in human volunteers. , 1998, The American journal of physiology.
[4] Yubo Sun,et al. Oxidative phosphorylation dysfunction modulates expression of extracellular matrix--remodeling genes and invasion. , 2006, Carcinogenesis.
[5] J. Bussink,et al. TUMOR MICROENVIRONMENT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS : PREDICTIVE VALUE AND CLINICAL RELEVANCE OF HYPOXIC MARKERS , 2007 .
[6] F. López-Ríos,et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. , 2007, Cancer research.
[7] A. Alavi,et al. Staging with PET and the “Will Rogers” effect: redefining prognosis and survival in patients with cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[8] Emma Saavedra,et al. Energy metabolism in tumor cells , 2007, The FEBS journal.
[9] J. Ehrhardt,et al. Assessment of Blood Flow in Solid Tumors Using PET. , 1998, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[10] P. Therasse,et al. Evaluation of response: new and standard criteria. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] Thomas Scholbach,et al. pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? , 2007, BMC Cancer.
[12] M. Phelps,et al. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] W. Weber. Positron emission tomography as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] E. Nissinen,et al. The energy charge in wild‐type and respiration‐deficient chinese hamster cell mutants , 1980, Journal of cellular physiology.
[15] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.
[16] Chi-Lai Ho,et al. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] Jacques Bernier,et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.
[18] B. Långström,et al. 1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[19] H R Schelbert,et al. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. , 1990, Circulation.
[20] P. Malmström,et al. Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy. , 2006, Urology.
[21] M E Phelps,et al. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. , 1989, Circulation.
[22] M. Janier,et al. Validation of Renal Oxidative Metabolism Measurement by Positron-Emission Tomography , 2007, Hypertension.
[23] M. Ristow. Oxidative metabolism in cancer growth , 2006, Current opinion in clinical nutrition and metabolic care.
[24] David L Buckley,et al. Imaging vascular physiology to monitor cancer treatment. , 2006, Critical reviews in oncology/hematology.
[25] Jens Sörensen,et al. [18F]Fluoroacetate is not a functional analogue of [11C]acetate in normal physiology , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[26] O. Warburg. On respiratory impairment in cancer cells. , 1956, Science.
[27] M. Eble,et al. Oxygenation of Advanced Head and Neck Cancer: Prognostic Marker for the Response to Primary Radiochemotherapy , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[28] J. Nelson,et al. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model , 2003, The Prostate.
[29] A. Maitra,et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck , 2007, Proceedings of the National Academy of Sciences.
[30] I. Nishimoto,et al. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. , 2004, Oral oncology.